VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CHEKCheck-Cap Ltd.
$1.86$11M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

CHEK logoCheck-Cap Ltd.(CHEK)Earnings, Financials & Key Ratios

CHEK•NASDAQ
Price updated Jun 4, 2026
SectorHealthcareIndustryDiagnostics & ResearchSub-IndustryDiagnostic Imaging Systems and Services
AboutCheck-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.Show more
  • Revenue$0
  • EBITDA-$26M-35.2%
  • Net Income-$25M-43.2%
  • EPS (Diluted)-4.30-43.3%
  • ROE-226.19%-318.4%

CHEK Key Insights

Check-Cap Ltd. (CHEK) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗Weak Piotroski F-Score: 2/9
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when CHEK posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CHEK Price & Volume

Check-Cap Ltd. (CHEK) stock price & volume — 10-year historical chart

Loading chart...

CHEK Growth Metrics

Check-Cap Ltd. (CHEK) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-46.56%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-46.26%

Return on Capital

10 Years-108.79%
5 Years-101.02%
3 Years-111.57%
Last Year-233.22%

CHEK Peer Comparison

Check-Cap Ltd. (CHEK) competitors in Diagnostic Imaging Systems and Services — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
GXAI logoGXAIGaxos.ai Inc.Direct Competitor8.69M1.22-2.22479.02%-131.27%-34.42%
CLOV logoCLOVClover Health Investments, Corp.Direct Competitor2.59B5.00-29.4140.34%-2.58%-17.08%
AEYE logoAEYEAudioEye, Inc.Direct Competitor78.83M6.31-25.2414.52%-9.05%-70.95%2.75
AEMD logoAEMDAethlon Medical, Inc.Direct Competitor1.44M1.89-0.18-137.73%0.07
GKOS logoGKOSGlaukos CorporationProduct Competitor7.65B130.68-39.8432.33%-34.34%-26.46%0.21
ANGO logoANGOAngioDynamics, Inc.Product Competitor505.13M12.15-14.64-3.76%-9.02%-15.71%
CERS logoCERSCerus CorporationProduct Competitor541M2.70-32.9314.35%-4.41%-15.18%1.49
PRCT logoPRCTPROCEPT BioRobotics CorporationProduct Competitor1.24B21.72-12.6337.22%-31.82%-27.7%0.14

Compare CHEK vs Peers

Check-Cap Ltd. (CHEK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs GXAI

Most directly comparable listed peer for CHEK.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare CHEK against a more recognizable public peer.

Peer Set

Compare Top 5

vs GXAI, CLOV, AEYE, AEMD

CHEK Income Statement

Check-Cap Ltd. (CHEK) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Sales/Revenue
244K00000000
Revenue Growth %
41.04%-100%-------
Cost of Goods Sold
130K157K148K115K148K205K405K212K161K
COGS % of Revenue
53.28%--------
Gross Profit
114K▲ 0%
-157K▼ 237.7%
-148K▲ 5.7%
-115K▲ 22.3%
-148K▼ 28.7%
-205K▼ 38.5%
-405K▼ 97.6%
-212K▲ 47.7%
-161K▲ 24.1%
Gross Margin %
46.72%--------
Gross Profit Growth %
40.74%-237.72%5.73%22.3%-28.7%-38.51%-97.56%47.65%24.06%
Operating Expenses
9.06M10M11.06M14.07M13.93M17.32M20.03M17.65M25.95M
OpEx % of Revenue
3713.93%--------
Selling, General & Admin
3.57M3.16M3.44M3.6M3.92M4.97M5.76M9.55M9.46M
SG&A % of Revenue
1463.52%--------
Research & Development
5.49M6.84M7.62M10.47M10.01M12.35M14.27M8.29M0
R&D % of Revenue
2250.41%--------
Other Operating Expenses
0000000-195K16.49M
Operating Income
-9.06M▲ 0%
-10M▼ 10.4%
-11.06M▼ 10.6%
-14.07M▼ 27.2%
-13.93M▲ 1.0%
-17.32M▼ 24.3%
-20.03M▼ 15.7%
-19.29M▲ 3.7%
-25.95M▼ 34.5%
Operating Margin %
-3713.93%--------
Operating Income Growth %
27.29%-10.36%-10.62%-27.17%0.97%-24.33%-15.66%3.73%-34.54%
EBITDA
-8.93M-9.84M-10.91M-13.95M-13.78M-17.12M-19.63M-19.07M-25.79M
EBITDA Margin %
-3660.66%--------
EBITDA Growth %
27.8%-10.21%-10.88%-27.84%1.22%-24.17%-14.68%2.82%-35.19%
D&A (Non-Cash Add-back)
130K157K148K115K148K205K405K212K161K
EBIT
-9.06M-10M-10.58M-14.07M-13.83M-17.19M-19.1M-17.86M-9.46M
Net Interest Income
132K59K236K237K57K106K914K1.76M800K
Interest Income
139K66K243K245K69K119K926K1.77M809K
Interest Expense
7K7K7K8K12K13K12K13K9K
Other Income/Expense
244K236K473K233K86K119K926K293K800K
Pretax Income
-8.82M▲ 0%
-9.77M▼ 10.7%
-10.59M▼ 8.4%
-13.84M▼ 30.7%
-13.85M▼ 0.1%
-17.2M▼ 24.2%
-19.11M▼ 11.1%
-17.57M▲ 8.1%
-25.15M▼ 43.2%
Pretax Margin %
-3613.93%--------
Income Tax
8K6K-1K000000
Effective Tax Rate %
-0.09%-0.06%0.01%0%0%0%0%0%0%
Net Income
-8.83M▲ 0%
-9.77M▼ 10.7%
-10.59M▼ 8.4%
-13.84M▼ 30.7%
-13.85M▼ 0.1%
-17.2M▼ 24.2%
-19.11M▼ 11.1%
-17.57M▲ 8.1%
-25.15M▼ 43.2%
Net Margin %
-3617.21%--------
Net Income Growth %
28.19%-10.71%-8.37%-30.66%-0.07%-24.24%-11.08%8.06%-43.15%
Net Income (Continuing)
-8.83M-9.77M-10.59M-13.84M-13.85M-17.2M-19.11M-17.57M-25.15M
Discontinued Operations
000000000
Minority Interest
000000000
EPS (Diluted)
-146.10▲ 0%
-134.31▲ 8.1%
-52.19▲ 61.1%
-34.05▲ 34.8%
-9.12▲ 73.2%
-4.13▲ 54.7%
-3.37▲ 18.4%
-3.00▲ 11.0%
-4.30▼ 43.3%
EPS Growth %
40.97%8.07%61.14%34.76%73.22%54.71%18.4%10.98%-43.33%
EPS (Basic)
-146.10-134.31-52.19-34.05-9.12-4.13-3.37-3.00-4.30
Diluted Shares Outstanding
60.41K72.75K202.9K399.3K1.52M4.14M5.67M5.85M5.85M
Basic Shares Outstanding
60.41K72.75K202.9K399.3K1.52M4.14M5.67M5.85M5.85M
Dividend Payout Ratio
---------

CHEK Balance Sheet

Check-Cap Ltd. (CHEK) balance sheet — assets, liabilities & shareholders' equity

MetricDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Total Current Assets
11.88M7.4M14.98M8.44M18.42M52.75M42.63M24.86M265K
Cash & Short-Term Investments
11.64M7M14.21M7.68M17.78M51.56M41.7M24.76M265K
Cash Only
11.64M7M8.57M7.68M7.7M26.46M4.09M8.84M0
Short-Term Investments
005.64M010.08M25.1M37.61M15.91M265K
Accounts Receivable
0000142K206K88K44K0
Days Sales Outstanding
---------
Inventory
48K-89K0193K208K144K264K00
Days Inventory Outstanding
134.77--612.57512.97256.39237.93--
Other Current Assets
090K529K346K150K356K311K21K0
Total Non-Current Assets
414K503K452K994K1.22M2.91M2.81M161K112K
Property, Plant & Equipment
414K503K452K994K1.22M2.91M2.81M161K112K
Fixed Asset Turnover
0.59x--------
Goodwill
000000000
Intangible Assets
000000000
Long-Term Investments
000000000
Other Non-Current Assets
000000000
Total Assets
12.29M▲ 0%
7.91M▼ 35.7%
15.44M▲ 95.2%
9.43M▼ 38.9%
19.64M▲ 108.3%
55.66M▲ 183.4%
45.44M▼ 18.4%
25.02M▼ 44.9%
377K▼ 98.5%
Asset Turnover
0.02x--------
Asset Growth %
-19.63%-35.7%95.24%-38.92%108.27%183.42%-18.36%-44.95%-98.49%
Total Current Liabilities
1.37M1.56M2.22M2.8M2.98M4.04M3.41M1.33M1.81M
Accounts Payable
393K608K1.11M989K862K1.05M952K141K492K
Days Payables Outstanding
1.1K1.41K2.74K3.14K2.13K1.87K857.98242.761.12K
Short-Term Debt
000222K264K350K337K00
Deferred Revenue (Current)
000000000
Other Current Liabilities
246K352K249K490K81K330K521K783K142K
Current Ratio
8.69x4.74x6.75x3.01x6.18x13.05x12.51x18.69x0.15x
Quick Ratio
8.66x4.80x6.75x2.94x6.11x13.02x12.43x18.69x0.15x
Cash Conversion Cycle
---------
Total Non-Current Liabilities
521K439K185K393K279K927K721K016K
Long-Term Debt
000000000
Capital Lease Obligations
000211K125K795K627K016K
Deferred Tax Liabilities
000000000
Other Non-Current Liabilities
521K439K185K182K154K132K94K00
Total Liabilities
1.89M2M2.41M3.19M3.26M4.97M4.13M1.33M1.83M
Total Debt
000433K389K1.15M964K0136K
Net Debt
-11.64M-7M-8.57M-7.25M-7.31M-25.31M-3.13M-8.84M136K
Debt / Equity
---0.07x0.02x0.02x0.02x--
Debt / EBITDA
---------
Net Debt / EBITDA
---------
Interest Coverage
-1294.57x-1428.71x-1580.43x-1758.63x-1161.00x-1332.38x-1669.50x-1483.62x-2883.22x
Total Equity
10.41M▲ 0%
5.91M▼ 43.3%
13.03M▲ 120.7%
6.23M▼ 52.2%
16.38M▲ 162.7%
50.69M▲ 209.5%
41.31M▼ 18.5%
23.69M▼ 42.7%
-1.45M▼ 106.1%
Equity Growth %
-17.72%-43.26%120.66%-52.16%162.72%209.51%-18.5%-42.66%-106.12%
Book Value per Share
172.2781.1764.2215.6110.7912.247.284.05-0.25
Total Shareholders' Equity
10.41M5.91M13.03M6.23M16.38M50.69M41.31M23.69M-1.45M
Common Stock
771K974K3.46M5.41M31.65M68.79M83.66M83.75M83.75M
Retained Earnings
-42.94M-52.71M-63.3M-77.14M-90.98M-108.19M-127.29M-144.86M-170.01M
Treasury Stock
000000000
Accumulated OCI
-462K-619K-13K000000
Minority Interest
000000000

CHEK Cash Flow Statement

Check-Cap Ltd. (CHEK) cash flow — operating, investing & free cash flow history

MetricDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Cash from Operations
-7.92M-9.15M-10.03M-12.84M-13.11M-16.26M-18.71M-16.95M-8K
Operating CF Margin %
-3247.13%--------
Operating CF Growth %
8.17%-15.49%-9.66%-27.99%-2.1%-24.03%-15.02%9.37%99.95%
Net Income
-8.83M-9.77M-10.59M-13.84M-13.85M-17.2M-19.11M-17.57M-25.15M
Depreciation & Amortization
130K157K147K115K148K205K404K212K161K
Stock-Based Compensation
1.21M726K-65K516K408K491K879K-57K12K
Deferred Taxes
00000-539K000
Other Non-Cash Items
-56K-165K67K40K7K539K-624K1.73M24.97M
Working Capital Changes
-380K-97K406K322K170K242K-258K-1.27M-12
Change in Receivables
000000000
Change in Inventory
000000000
Change in Payables
-252K275K416K503K-317K362K207K-851K497K
Cash from Investing
4.69M-231K-5.72M5.45M-10.45M-16.01M-12.51M21.36M-840
Capital Expenditures
-166K-231K-94K-167K-379K-1.01M-486K-83K0
CapEx % of Revenue
68.03%--------
Acquisitions
000000000
Investments
---------
Other Investing
4.86M0-5.63M00000-840
Cash from Financing
5.42M4.58M17.76M6.51M23.58M51.02M8.85M00
Debt Issued (Net)
000000000
Equity Issued (Net)
1000K1000K1000K1000K1000K1000K1000K00
Dividends Paid
000000000
Share Repurchases
00-30K000000
Other Financing
117K196K00019.22M000
Net Change in Cash
2.25M▲ 0%
-4.64M▼ 306.6%
1.93M▲ 141.5%
-887K▼ 146.1%
18K▲ 102.0%
18.75M▲ 104088.9%
-22.36M▼ 219.3%
4.4M▲ 119.7%
-8.84K▼ 100.2%
Free Cash Flow
-8.09M▲ 0%
-9.38M▼ 16.0%
-10.13M▼ 8.0%
-13.01M▼ 28.5%
-13.49M▼ 3.7%
-17.27M▼ 28.0%
-19.19M▼ 11.1%
-17.04M▲ 11.2%
-8K▲ 100.0%
FCF Margin %
-3315.16%--------
FCF Growth %
9.09%-15.97%-7.96%-28.46%-3.7%-28%-11.13%11.23%99.95%
FCF per Share
-133.90-128.95-49.92-32.58-8.89-4.17-3.38-2.91-0.00
FCF Conversion (FCF/Net Income)
0.90x0.94x0.95x0.93x0.95x0.95x0.98x0.97x0.00x
Interest Paid
000000000
Taxes Paid
8K3K5K15K5K33K5K25K0

CHEK Key Ratios

Check-Cap Ltd. (CHEK) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2015201620172018201920202021202220232024
Return on Equity (ROE)
-165.24%-76.56%-119.8%-111.85%-143.65%-122.47%-51.3%-41.54%-54.06%-226.19%
Return on Invested Capital (ROIC)
-424.1%-671.59%--493%-613.47%-259.73%-75.43%-47.28%-54.56%-287.7%
Gross Margin
46.82%46.72%--------
Net Margin
-7104.05%-3617.21%--------
Debt / Equity
----0.07x0.02x0.02x0.02x--
Interest Coverage
-265.17x-1294.57x-1428.71x-1580.43x-1758.63x-1161.00x-1332.38x-1669.50x-1483.62x-2883.22x
FCF Conversion
0.70x0.90x0.94x0.95x0.93x0.95x0.95x0.98x0.97x0.00x
Revenue Growth
121.95%41.04%-100%-------
Related:CHEK Dividend History·CHEK Revenue History·CHEK Price History·CHEK P/E History·CHEK Financial Ratios·CHEK Institutional Holders

CHEK Frequently Asked Questions

Check-Cap Ltd. (CHEK) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Check-Cap Ltd. (CHEK) grew revenue by 0.0% over the past year. Growth has been modest.

Check-Cap Ltd. (CHEK) reported a net loss of $25.1M for fiscal year 2024.

Dividend & Returns

Check-Cap Ltd. (CHEK) has a return on equity (ROE) of -226.2%. Negative ROE indicates the company is unprofitable.

Check-Cap Ltd. (CHEK) had negative free cash flow of $0.0M in fiscal year 2024, likely due to heavy capital investments.

What if you invested $1,000 in CHEK back in 2012?

Total return calculator · dividends reinvested · 14+ years of data

See returns →

How much would $100/month in CHEK be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →